AzTrials
AzTrials

Painful Bladder SyndromeNCT02856022

A Comparison of Electrical Ilioinguinal Nerve Stimulation With Intravesical Irrigation for Bladder Pain Syndrome

A study testing Electrical ilioinguinal nerve stimulation and Intravesical Irrigation in people with Painful Bladder Syndrome, run by Shanghai Institute of Acupuncture, Moxibustion and Meridian at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether electrical ilioinguinal nerve stimulation (EINS) is more effective than intravesical irrigation (II) in treating bladder pain syndrome. Read more about this study

Who is it for?
Ages 18 to 80 years, women only
Conditions the study is for
Painful Bladder Syndrome
What is being tested?
Electrical ilioinguinal nerve stimulation and Intravesical Irrigation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteChina
Study dates
Jul 2014to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Providing informed consent to participate in the study;
  • Willing to undergo a cystoscopy under general or regional anesthesia when indicated during the course of the study;
  • Female patients meeting the diagnostic criteria;
  • Age ≥18 years and ≤80 years.
  • Disease course ≥ 6 months

Who cannot join

  • Bladder capacity of greater than 350 mL on awake cystometry;
  • Absence of an intense urge to void with the bladder is filled to 150 mL of liquid filling medium;
  • The demonstration of phasic involuntary bladder contractions on cystometry using the fill rate just described;
  • Duration of symptoms less than 9 months;
  • Absence of nocturia;
  • Symptoms relieved by antimicrobial agents, urinary antiseptic agents, anticholinergic agents, or antispasmodic agents;
Show all 18Show fewer
  • A frequency of urination while awake of less than 8 times per day;
  • A diagnosis of bacterial cystitis or prostatitis within a 3-month period;
  • Bladder or ureteral calculi;
  • Active genital herpes;
  • Uterine, cervical, vaginal, or urethral cancer;
  • Urethral diverticulum;
  • Cyclophosphamide or any type of chemical cystitis;
  • Tuberculous cystitis;
  • Radiation cystitis;
  • Benign or malignant bladder tumors;
  • Vaginitis;
  • Age younger than 18 years.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Shanghai research institute of acupuncture and meridian

    Shanghai, 200030

Other trials in China

About this study

Official title: A Comparison of the Efficacy of Electrical Ilioinguinal Nerve Stimulation and Intravesical Irrigation in Treating Patients With Bladder Pain Syndrome in Women

The purpose of this study is to determine whether electrical ilioinguinal nerve stimulation (EINS) is more effective than intravesical irrigation (II) in treating bladder pain syndrome.

Read the detailed description

The purpose of this study is to determine whether electrical ilioinguinal nerve stimulation (EINS) is more effective than intravesical irrigation (II) in treating bladder pain syndrome.

Being tested
Electrical ilioinguinal nerve stimulation, Intravesical Irrigation
Keywords
electrical ilioinguinal nerve stimulation, bladder pain syndrome, intravesical irrigation
Medical subject headings
Cystitis, Interstitial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electrical ilioinguinal nerve stimulationDevice

    Four abdominal points are selected. The upper two points are located 2.5 cun bilateral to Guanyuan (Ren 4). The lower two points are located 1.5 cun bilateral to Zhongji (Ren 3). Four long needles are punctured obliquely 1~2 cun in depth (depending on the fat layer thickness of the patient) to the four points to make the needling sensation reaching the urethra or vulva.

    After the needling sensation reach the above regions, each of two pairs of electrodes from a device are connected with the two ipsilaterally inserted needles. The parameters are continuous waves, a frequency of 2.5 Hz and intensity that the patient feels comfortable for 60 min, three times a week for at least four weeks.

  • Intravesical IrrigationProcedure or surgery

    The patient was asked to lie on a couch in a lithotomy position after urination. A catheter was passed through the urethra into the bladder and any residual urine drained. The Cystistat 50mL 40mg (sodium hyaluronate, Bioniche Teoranta, Ireland) solution is instilled through the catheter into the bladder. The catheter is then withdrawn leaving the Cystistat inside the bladder coating the lining. It was recommended the solution was retained for as long as possible, ideally at least 30 minutes. The instillation is once weekly for at least four weeks.

Study groups in NCT02856022
Study groupRoleWhat they receive
Electrical ilioinguinal nerve stimulationExperimentalNot described
Receives: Device: Electrical ilioinguinal nerve stimulation
Intravesical IrrigationActive comparatorNot described
Receives: Procedure: Intravesical Irrigation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bladder Pain/ Interstitial Cystitis Symptom Score (BPIC-SS)

    Measured: 4 weeks

Secondary outcomes (1)
  1. SF-36 questionnaire

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2016 (estimated)
  2. Study startJul 2014
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02856022
Sponsor's protocol ID
ZYY201606
Status last verified
Jun 2016
First submitted
2 Aug 2016
Last updated
31 Jul 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Electrical ilioinguinal nerve stimulation and Intravesical Irrigation in people with Painful Bladder Syndrome, run by Shanghai Institute of Acupuncture, Moxibustion and Meridian at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bladder Pain/ Interstitial Cystitis Symptom Score (BPIC-SS) (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2017; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in